Background and Objective Perianal fistulae are a common complication of Crohn's disease (CD) and pose a substantial burden on quality of life. Data capturing health-related utility associated with perianal fistulae in CD are scarce. The current study aims to value health states related to different stages of the disease to quantitatively evaluate the impact of complex perianal fistulae on CD patients' quality of life. Methods Eight health state descriptions associated with complex perianal fistulae in CD were developed following qualitative research with patients and validation by clinicians. Following pre-testing, a survey was administered online in two samples of UK respondents: the general population and patients with CD. A choice-based valuation technique, the time trade-off (TTO), was used for direct utility measurement. CD patients also valued their current health state using the TTO. Exclusion criteria for respondents displaying logical inconsistencies were applied. Results Usable responses were received from 835 respondents, reflective of the UK population in age and sex, in the general population survey and 162 CD patients in the patient survey. Non-remission states were valued much lower than the remission state by both samples, ranging from 0.20 for proctectomy with a negative outcome to 0.66 for chronic symptomatic fistulae with mild symptoms. Patients currently experiencing fistulae reported lower values for current health than those without fistulae. Conclusion Low utility values were assigned to the non-remission health states for perianal fistulae in CD by the general public and patients with CD. This demonstrates the high humanistic burden of inadequately managed perianal fistula in CD.
Introduction
Perianal fistulae are a common complication of Crohn's disease (CD), occurring in 20-50% of patients [1, 2] . They are usually the result of an infection near the anus causing a collection of pus (abscess) in the nearby tissue, creating a small tunnel that develops between the end of the bowel and the skin near the anus. A recent study measured health-related quality of life (HRQoL) in patients with and without perianal fistula and found that those with a perianal condition reported a lower quality of life on all different subscales using SF-36 [3] . Patients' HRQoL can be seriously affected by perianal fistulae in several ways, such as development of fecal incontinence caused by the disease itself or as a complication of surgery [4] , recurrent infections and sepsis [5] , psychological problems including anxiety, depression and poor body image [6, 7] , restricted sexual activity [8] , fewer pregnancies [9] , and restricted social interactions and employment [6] . Of all of the symptoms of perianal fistulae in CD patients, physical symptoms such as anal pain and discharge were felt to be the most important and unfavourable by the patients [8] .
There is evidence available on how perianal fistulae affect aspects of the HRQoL of CD patients; however, data capturing health-related utility weights associated with perianal fistula is scarce. Health-related utility measures are useful for capturing the value placed on different health effects, where utility is defined on a scale of 1 (full health) and 0 (dead), and it is routinely used in the economic evaluation of health technologies. A range of methods are available to obtain health-related utility data; the most commonly used methods are standardised preference-based questionnaires, such as the EQ-5D and Health Utilities Index (HUI) measures [10] [11] [12] . Alternative approaches include 'mapping' to predict utility data from other outcome measures and direct valuation of health states described using 'vignettes' [13, 14] . Many health technology assessment (HTA) agencies require health-related utility data to be included in their assessments to inform reimbursement decisions; however, their recommended methods vary.
There is a lack of health-related utility data reported in the literature that assessed health states related to CD. The most relevant health states were included in a study by Arseneau et al. [15] , in which utility values were elicited directly from 32 CD patients (17 fistulising and 15 nonfistulising) and 20 healthy individuals, using the standard gamble technique. The mean utilities estimated by CD patients for fistulae before treatment with infliximab and 6-mercaptopurine (6MP) plus metronidazole were 0.73 and 0.69, respectively. The same health states were valued by a healthy sample at 0.77 and 0.75, respectively. Improved fistula using infliximab and 6MP plus metronidazole were valued higher at 0.85 and 0.81 by CD patients and at 0.91 and 0.88 by the general public. Perianal abscess was valued at 0.62 and 0.72 by CD patients and the general public, respectively. However, a detailed description of the health states valued is not reported in the paper. Further, the authors have not provided any information about the standard gamble (SG) valuation method [15] .
In the absence of robust published evidence on healthrelated utilities associated with perianal fistulae in CD, this study sought to elicit utility values for use in economic evaluations of treatments for perianal fistulae in CD. Alternative approaches such as a mapping approach to predict EQ-5D values from disease-specific measures of disease activity, such as the Perianal Disease Activity Index (PDAI), were considered. For this approach to be successful, a degree of conceptual overlap between the two measures is required [14] as well as an empirical dataset utilising both measures. Based on an evaluation of the content of PDAI, there was some overlap between dimensions of disease activity included within the PDAI (discharge, pain, restriction of sexual activity) with HRQoL dimensions, but others were more clinically focused. A similar conclusion was drawn by Buxton et al. [16] about another measure of disease severity in CD, the Crohn's Disease Activity Index (CDAI) and the EQ-5D.
Eliciting utilities using descriptions of health states (a vignette approach) has previously been used to successfully generate health-related utility values [13] and was selected as an alternative approach. This approach enables the elicitation of utility values from both the general population and from patients, and so can be used to meet the various needs of different HTA agencies. For example, some HTA agencies such as the TLV (Dental and Pharmaceutical Benefits Agency) in Sweden prefer utility values to be elicited directly from patients, whereas others recommend obtaining values from the general population [12] .
The aim of this study was to conduct a valuation of health states relating to disease progression of complex perianal fistulas in CD, as well as major surgeries associated with it, using a 'vignette' approach. Two samples of UK respondents were approached to value the health states: the general population and patients with CD. A choice-based valuation technique, the time trade-off (TTO), was used to directly elicit utility values.
Methods

Summary of Vignette Development
Qualitative interviews with patients were conducted to obtain patients' perspectives of the impact of perianal fistulae and CD on their quality of life. A discussion guide was developed for the interviews, which included questions about the patients' experiences of CD, perianal fistulae, abscesses, surgeries and how these impacted on their lives. In addition, focused questions on patients' definitions of fistulae as well as specific impacts of fistulae based on a review of the PDAI content were included (pain, discomfort, restriction on daily activities, discharge from the fistula, hardening of the skin around the fistula, and bowel movements).
Following the patient interviews, eight vignettes were developed. These vignettes were reviewed by two clinical experts for clarity and relevance to perianal fistulae in CD. Subsequently, a second series of interviews with CD patients was undertaken to test the face validity and comprehension of the vignettes' description and wording. The vignettes were then refined in line with feedback from the final patient interviews.
The eight vignettes included four non-surgical health states: remission, chronic symptomatic fistulae with mild symptoms, chronic symptomatic fistulae with severe symptoms, and abscess. The remaining four states related to surgery: defunctioning, which includes colostomy and ileostomy, with positive and negative outcomes; and proctectomy, with positive and negative results. The final vignettes used in the survey are described in the Electronic Supplementary Material.
Valuation Method
There are two choice-based approaches available for valuation: the SG and TTO techniques.
The TTO method was selected to estimate utility values as it is a well-established and researched elicitation procedure and is also the method used to value the EQ-5D instrument (in order to increase comparability with utility values obtained using EQ-5D). The objective of the TTO is to determine the length of life the respondent would be willing to forego to live in a better health state (typically 'full health') and avoid living in a compromised health state. Respondents are presented with a series of choice tasks, each involving two alternative hypothetical lives. They are then asked to choose between living a longer life in the health state of interest and a shorter life in better health. Depending on which life is chosen, the amount of time in better health is altered until a point of preferential indifference is reached [18] . There are numerous ways to implement TTO, e.g. depending on the framework used, conventional TTO or composite TTO.
The specific TTO methodology was designed to follow the international protocol used to value the EQ-5D-5L as far as possible [17, 18] . The EQ-5D-5L protocol was informed by a multi-country, multi-stage research program [19] and has been used in a number of EQ-5D-5L valuation studies since its first version (version 1.0) became available in 2012. Specific elements of the protocol designed to match the EQ-5D-5L protocol were including the composite TTO framework [20] , which uses conventional TTO and leadtime TTO.
For the TTO valuation in this study, respondents were presented with paired choices. Full health was compared with each of the eight health states separately and the respondent was asked which health state they thought was better, i.e. Life A ('full health') or Life B (the impaired health state described by the vignette). Respondents were asked to imagine what it would be like to live in each health state for the indicated period of time without relief or treatment and with the assumption that death would follow this period. The participants were also asked to imagine that they had no health problems other than those described. In the patient survey, in addition to the eight health state vignettes, the CD patients were also asked to value their current health state. The routing used to program the survey logic for the TTO and lead time TTO survey questions was adapted from the EQ-5D-5L protocol.
This valuation framework starts with the conventional TTO for all health states (see Fig. 1 ). Initially, respondents are asked to choose between 10 years in full health or 10 years in the impaired state, and then to consider whether no years in full health (dead) is better than 10 years in the impaired state. If the respondent considered the impaired (vignette) health state to be better than dead (BTD), the conventional TTO is used again. However, if the respondent considered his/her health state to be worse than dead (WTD), the lead-time TTO is used (see Fig. 2 ). The number of years in the full health state is varied in 1-year increments until respondents indicate a switch in preferences for the alternative state, and a final question asked using a 6-month increment. The TTO task terminates when the respondent states indifference or indicates a preference reversal. This allows resulting utility values to range from − 1 to 1, with the smallest difference between values being 0.05.
Online Survey Development and Administration
The TTO survey was developed using an online platform and administered to an online panel of 1040 members of the general public and 201 CD patients. In the general public sample, panel quotas were set within the survey to ensure the recruited sample reflected the national population in terms of age and sex. Each participant was provided with a unique identification number and all responses remained anonymous at all times.
A pilot study in the form of a 'soft launch' of the survey was conducted to check the validity of the survey design and analyses were performed to check the consistency of the participants' responses. Following amendments to the survey, a second 'soft launch' was conducted and data from the initial launch were discarded. Minor amendments were made to the survey following the second 'soft launch' and the remaining participants completed the survey. A minimum time to completion of 5 min was placed on the survey based on analysis of inconsistent respondents and time taken to complete the survey in the pilot study; data from respondents completing the survey under this time were not recorded.
Respondents were initially asked to complete an example TTO to ensure they understood the question format that would be presented throughout the survey. To familiarise the respondents with the health states, the respondents were asked to rank health states 1-4, which were related to general CD with perianal fistulae, and health states 5-8, which were surgical states related to CD with perianal fistulae, in order of severity.
To avoid a framing effect and response fatigue at the end of the survey, the order in which respondents answered questions for health states 1-4 and health states 5-8 was randomised. To ensure participants were engaged in the survey, simple attention check questions were included within the surveys. Following completion of the preference questions, respondents were asked general background questions. The patients were asked additional questions about their CD.
Time Trade-Off (TTO) Analysis
The utility values associated with BTD and WTD health states are estimated differently and are described below. Each TTO task ends when the participant indicates that the two hypothetical health states are 'about the same'.
Conventional TTO (Better Than Dead)
To calculate the health state value (V) associated with the BTD health state, the total number of years in Life A (x) is divided by the total number of years in Life B (t):
Lead-Time TTO (Worse Than Dead)
To calculate the health state value (V) associated with the WTD health state, the number of years of lead time (l) is subtracted from the total number of years in Life A (x), and is then divided by the total number of years in Life B (t):
This approach allows the patient to trade-off more years and attaches negative utility values to the health states they consider worse than death.
Inconsistent Results
A set of decision rules was adopted to identify and exclude inconsistent responses. These were designed to be similar to those used for the UK valuation of EQ-5D-5L [21] , which excluded all responses that gave all health states the same value and which valued the best health state lower than the worst. The decision rules for exclusion in our analysis included providing the same value to all health states and
assigning a lower value to the remission state than a severe health state. The severe health states chosen for comparison were abscess, defunctioning surgery with a negative outcome and proctectomy with a negative outcome. The characteristics of respondents who provided inconsistent results were examined using t tests on socioeconomic variables, completion of the ranking exercise and time taken to complete the survey. In order to ensure good-quality data, respondents with inconsistent responses were excluded from the analysis.
Subgroup Analyses
Exploratory subgroup analyses were conducted to examine the difference in preferences across different backgrounds of the general population sample and experiences of CD. Regression analysis using an ordinary least squares model was carried out for each health state separately, with utility as the dependent variable. Sociodemographic variables and health-related questions were included as explanatory variables such as age, sex, time taken to complete the survey and experience of CD. Variables that were statistically significant (p < 0.05) were identified. The models were assessed for consistency in the direction and statistical significance of coefficients across health states.
Results
Inconsistent Respondents
The survey was administered online to the general population and patients between June and August 2017. A summary of inconsistent responses is provided in Table 1 . On average, 19.6% of respondents were excluded from the surveys as they displayed one or more logical inconsistency in their responses.
Respondent Demographic
A summary of respondent characteristics from the population and patient survey is presented in Table 2 . A total of 835 members of the general public were included in the analysis. Generally, with the exception of those aged over 65 years, the recruited sample reflected the UK national population in terms of age and sex according to the 2011 UK Census [22] . Of the 162 CD patients included in the study, 33.3% of the participants had experienced perianal fistula, 36.4% had experienced perianal abscess, 26.5% had experienced abdominal abscess and nearly half (46.9%) had undergone surgery for CD. Of the 76 respondents who underwent surgery, a total of 22 had undergone colostomy, 31 had an ileostomy, ten had a proctectomy and 48 indicated other surgeries such as bowel resection and fistula drainage. Some patients indicated that they had undergone more than one surgery.
TTO Results
The responses to the TTO questions for each health state were converted into utilities and are presented in Table 3 .
The mean values followed a logical pattern from least to most severe (highest to lowest utility). In both samples, the remission state of non-active perianal CD was valued 'highest' (general population: 0.87; patients: 0.89) followed by chronic symptomatic fistulae with mild symptoms (general population: 0.58; patients: 0.66). Defunctioning surgery with negative outcomes (general population: 0.19; patients: 0.28) and proctectomy surgery with negative outcomes (general population: 0.20; patients: 0.28) had the lowest utility values. In the patient 
Subgroup Analyses
Respondents to the public survey who had experience of CD, including family or friends with CD, valued all of the health states slightly higher than those without family or friends with CD (see Fig. 3 ). In the population sample, on average, men valued all health states higher than women, although this was Fig. 3 Utility estimates from the general public only statistically significant for one state (remission). The difference was statistically significant for five health states and these are highlighted in Fig. 3 . Time taken to complete the survey and age also significantly impacted on the outcome of the survey for some health states, although there was no clear and consistent pattern across the range of health state severities (see Electronic Supplementary Material for detailed information).
In the patient sample, none of the variables were statistically significant (p < 0.05) in explaining the variance in health state utility based on the regression models that were estimated, possibly due to the small sample size. Participants who had undergone surgery or had an abscess (perianal or abdominal) at the time of the survey reported lower utility values across all hypothetical health states and current health states than those who had not undergone surgery or did not have an abscess at the time of the survey, respectively. The current health state utility value of patients with perianal fistula was 0.47 (n = 26) and of those with perianal abscess was 0.35 (n = 21); this was much lower than in patients not currently experiencing these conditions and had a utility value of 0.75 (see Table 4 ). Only 76 patients reported undergoing CD-related surgery, and these patients had a current health state utility value of 0.66, compared with those without any surgery who had a mean utility value at 0.75 (n = 84).
Discussion
To our knowledge, this is the largest utility study in CD patients with perianal fistula. The impact of the disease was described in terms of symptoms such as pain (or discomfort), discharge, incontinence, and restrictions in daily activities and sexual activity, based on qualitative studies conducted with CD patients. The respondents within both samples valued the remission state of non-active perianal CD the highest. Nonremission states were valued much lower than the remission state, ranging from 0.20 for proctectomy with a negative outcome to 0.66 for chronic symptomatic fistulae with mild symptoms. Defunctioning (colostomy or ileostomy) and proctectomy surgery with negative outcomes had the lowest utility values, indicating very high preference to avoiding these health states. These findings demonstrate the perceived significant impact on HRQoL of inadequately managed perianal fistula in CD.
The two surveys produced broadly similar values. This provides evidence that the estimates are robust and not subject to significant random error. However, patients reported slightly higher values than the general population for some states. This is consistent with our finding from the general population survey in which the respondents who had experience of CD, including family or friends with CD, valued all of the health states slightly higher than those without any experience of CD. Empirical analyses reported in the literature have also demonstrated that valuation of health states by patients and the general population differ. This is due to a number of reasons such as adaptation to the state, changes in internal standards and errors in descriptive system [24] .
Most international HTA agencies (e.g. Canada, France, The Netherlands, Spain, UK) prefer that a representative sample of the public is used to provide preference weights rather than patients or clinicians/experts. However, some HTA agencies such as TLV in Sweden recommend eliciting preference weights from patients.
The patient study had a sample of 162 patients with CD (after patients with inconsistent responses were excluded) and participation was not limited to CD patients with complex perianal fistulae due to recruitment challenges. This meant that not all patients included in the study had direct experience of the hypothetical complex perianal fistula health states they were valuing. However, they are likely to have a better understanding of it than other patients. The study focused on eliciting values for hypothetical health states but valuation of current health state was also included in the patient survey. For example, 26 patients currently experiencing fistula had a mean value of 0.47 for their current health state. However, the sample size was not sufficient to fully examine patients experiencing the specific health states valued in this study. For example, only ten CD patients included in the survey had undergone proctectomy.
A recent article by Malinowski and Kawalec [25] reporting a systematic review of health utility of patients with CD and ulcerative colitis (UC) was selected to compare and contrast our study to similar studies in the literature. A total of 30 studies reporting utilities for CD, UC or inflammatory bowel disease (IBD) were identified. Seventeen studies focused on CD and four studies on IBD or UC but reported surgical states that are similar to those described in this study. The utility values obtained from the literature are similar to those elicited in our study. Overall, the utility scores estimated in this study capture more granular health states than those reported in the literature. The mean value for the perianal disease state in remission in our study (population: 0.87; patients: 0.89) was in a similar range to values reported for remission states in other studies which had mean of 0.8-0.96 and median of 0.77-1 [25] . The mean value for abscess in our study (0.34) was much lower than that reported by Arseneau et al. [15] at 0.62. The mean utility for chronic symptomatic fistulae in our study with mild symptoms (0.58) was lower than reported in the literature for fistulising disease, which ranged from 0.69 to 0.85 [25] . Since the health states or vignettes valued in the Arseneau et al. [15] study are not reported, it is difficult to explain the discrepancy. However, it is possible that the condition described was of simple fistulas rather than complex perianal fistula, which was the focus of this study. It was not possible to find a comparable estimate from the literature review for other health states valued in this study. To our knowledge, the only study that estimated utility in patients with fistula is by Grucela et al. [26] . The study used the EQ-5D to prospectively evaluate quality of life of patients with fistula or fissure undergoing anorectal surgery. It included 159 patients and estimated the mean utility in preoperative and postoperative anorectal surgery patients. A total of 73 patients in the sample had a fistula diagnosis, and their mean utility estimates were 0.82 and 0.87. Patients with fissure (n = 61) who had anorectal surgery reported utilities of 0.61 and 0.70, respectively. The tariff set used in this study is not reported.
A limitation of our study is the use of condition-specific vignettes (as opposed to a generic measure) that may cause a focusing effect, whereby attention is drawn to health problems that may not be considered so severe when placed in the context of a broader description of health [27] . In order to assess comparability with standardised generic preference-based measures, consideration was given to the utility values associated with EQ-5D-3L health states with similar descriptors for elements of the vignettes. The vignette describing mild symptoms most closely corresponds to EQ-5D-3L health states 11221 and 11222, including mild problems with usual activities and pain/discomfort, and no or mild anxiety/depression. The utility values assigned to these health states in the UK are 0.760 and 0.689, respectively, compared to the mild state estimated in this study and valued at 0.578 (using the public sample). Remission, defined as no symptoms related to perianal fistulae, was valued in this study (by the public sample) as 0.865 and would correspond to the EQ-5D-3L health state of 11111 (no problems) valued as 1. It should, however, be recognised that it is the magnitude of the differences or changes in health state values that affects the results of economic evaluations. Both the EQ-5D and vignette approaches give estimates of differences in values of a broadly similar range (0.28 vignette approach and 0.24-0.31 for the EQ-5D).
A strength of the study is that it employed a relatively large sample size compared to existing literature and administered the preference surveys to both the general population and patients with CD. Also, qualitative interviews were undertaken with patients to inform the development of the vignettes. A potential limitation of the study is the number of inconsistent responses. Comprehension of the TTO exercise was examined during pre-testing; however, some patients may still have had difficulties understanding the exercise without an interviewer.
Conclusion
This study demonstrates that the HRQoL of patients is significantly impacted by perianal fistula in CD. It is the first study to empirically estimate the utility value of health states in CD patients with perianal fistula using a robust valuation technique. Patients reported slightly higher values than the general population for some states; however, the surveys produced broadly similar values.
